| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.21e-11 | 37 | 110 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.79e-11 | 38 | 110 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 SMARCA5 DDX12P ATRX CHD9 ERVK-7 ERVK-10 ERVK-8 SMARCA2 SMARCA4 DDX11L8 | 2.18e-07 | 262 | 110 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.79e-07 | 11 | 110 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 8.36e-07 | 14 | 110 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.75e-06 | 37 | 110 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.85e-06 | 21 | 110 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.59e-06 | 127 | 110 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 NUP85 SEPTIN4 KRT74 ERVK-7 ERVK-21 SEC31A ERVK-9 ERVK-10 KRT40 CLTC ERVK-8 ERVK-5 ERVK-19 SEPTIN7 ERVK-24 RPL5 | 7.36e-06 | 891 | 110 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | endopeptidase activity | TPP2 ERVK-6 USP34 USP9X ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24 | 2.56e-05 | 430 | 110 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | helicase activity | 2.73e-05 | 158 | 110 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | interleukin-8 receptor activity | 3.01e-05 | 2 | 110 | 2 | GO:0004918 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.00e-05 | 37 | 110 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.57e-05 | 38 | 110 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | interleukin-8 binding | 8.99e-05 | 3 | 110 | 2 | GO:0019959 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 FBXO40 HIVEP1 RNF19B BIRC2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TAB3 TRAF4 ERVK-8 ERVK-5 ERVK-19 ERVK-24 | 1.10e-04 | 891 | 110 | 15 | GO:0008270 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.19e-04 | 46 | 110 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | ubiquitin-specific protease binding | 1.73e-04 | 20 | 110 | 3 | GO:1990381 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 1.79e-04 | 4 | 110 | 2 | GO:0045142 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 SMARCA5 DDX12P ATRX POLR2E CHD9 ERVK-7 ERVK-10 ERVK-8 SMARCA2 SMARCA4 DDX11L8 | 2.28e-04 | 645 | 110 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | peptidase activity | TPP2 ERVK-6 USP34 USP9X ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP9Y ERVK-8 ERVK-19 ERVK-24 | 2.59e-04 | 654 | 110 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | DNA polymerase binding | 2.66e-04 | 23 | 110 | 3 | GO:0070182 | |
| GeneOntologyMolecularFunction | dermatan 4-sulfotransferase | 2.97e-04 | 5 | 110 | 2 | GO:0001537 | |
| GeneOntologyMolecularFunction | ubiquitin binding | 3.15e-04 | 107 | 110 | 5 | GO:0043130 | |
| GeneOntologyMolecularFunction | C-X-C chemokine binding | 6.20e-04 | 7 | 110 | 2 | GO:0019958 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 7.16e-04 | 128 | 110 | 5 | GO:0032182 | |
| GeneOntologyMolecularFunction | C-X-C chemokine receptor activity | 8.24e-04 | 8 | 110 | 2 | GO:0016494 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 9.53e-04 | 79 | 110 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 9.86e-04 | 206 | 110 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | SMARCA5 DDX12P ATRX SEPTIN4 RNF213 CHD9 ARL2 GNL2 SMARCA4 SEPTIN7 DDX11L8 VCP | 1.16e-03 | 775 | 110 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.54e-03 | 152 | 110 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.60e-03 | 11 | 110 | 2 | GO:0043139 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.91e-03 | 12 | 110 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | SMARCA5 DDX12P ATRX MYO7B RNF213 CHD9 SMARCA2 SMARCA4 DDX11L8 VCP | 2.09e-03 | 614 | 110 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 FBXO40 HIVEP1 RNF19B BIRC2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TAB3 TRAF4 ERVK-8 ERVK-5 ERVK-19 ERVK-24 | 2.20e-03 | 1189 | 110 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 2.21e-03 | 47 | 110 | 3 | GO:0051539 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | SMARCA5 DDX12P ATRX SEPTIN4 RNF213 CHD9 ARL2 GNL2 SMARCA4 SEPTIN7 DDX11L8 VCP | 2.26e-03 | 839 | 110 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | SMARCA5 DDX12P ATRX SEPTIN4 RNF213 CHD9 ARL2 GNL2 SMARCA4 SEPTIN7 DDX11L8 VCP | 2.28e-03 | 840 | 110 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | SMARCA5 DDX12P ATRX SEPTIN4 RNF213 CHD9 ARL2 GNL2 SMARCA4 SEPTIN7 DDX11L8 VCP | 2.28e-03 | 840 | 110 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.62e-03 | 14 | 110 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.06e-03 | 441 | 110 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 4.23e-03 | 59 | 110 | 3 | GO:0031593 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 4.34e-03 | 18 | 110 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | clathrin binding | 5.08e-03 | 63 | 110 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.81e-03 | 136 | 110 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 6.81e-03 | 136 | 110 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 7.05e-03 | 23 | 110 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 7.67e-03 | 24 | 110 | 2 | GO:0019957 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 7.67e-03 | 24 | 110 | 2 | GO:0043027 | |
| GeneOntologyBiologicalProcess | DNA integration | 5.09e-07 | 13 | 109 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell homeostasis | 9.25e-07 | 34 | 109 | 5 | GO:0061484 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 SMARCA5 AP5S1 DDX12P ATRX USP9X ERVK-7 ERVK-10 FANCI ERVK-8 SMARCA2 SMARCA4 DDX11L8 SLX4 VCP | 1.61e-06 | 648 | 109 | 15 | GO:0006281 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 5.37e-06 | 48 | 109 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | cell cycle process | TOM1L2 SMARCA5 DDX12P ATRX SEPTIN4 USP9X FEM1B ARL2 CENPM CLTC EXOC6B SMARCA2 SMARCA4 TTI1 CDT1 SEPTIN7 DDX11L8 SLX4 VCP LCMT1 NLRP5 NIN | 5.39e-06 | 1441 | 109 | 22 | GO:0022402 |
| GeneOntologyBiologicalProcess | DNA replication | ERVK-6 SMARCA5 DDX12P ATRX ERVK-7 ERVK-10 ERVK-8 CDT1 DDX11L8 SLX4 | 6.17e-06 | 312 | 109 | 10 | GO:0006260 |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 SMARCA5 AP5S1 DDX12P ATRX USP9X ERVK-7 ERVK-10 FEM1B FANCI ERVK-8 SMARCA2 SMARCA4 TTI1 DDX11L8 SLX4 VCP | 1.11e-05 | 959 | 109 | 17 | GO:0006974 |
| GeneOntologyBiologicalProcess | interleukin-8-mediated signaling pathway | 2.77e-05 | 2 | 109 | 2 | GO:0038112 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 SMARCA4 ERVK-5 ERVK-19 ERVK-24 VCP | 3.51e-05 | 464 | 109 | 11 | GO:0016032 |
| GeneOntologyBiologicalProcess | cellular response to interleukin-8 | 8.27e-05 | 3 | 109 | 2 | GO:0098759 | |
| GeneOntologyBiologicalProcess | response to interleukin-8 | 8.27e-05 | 3 | 109 | 2 | GO:0098758 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 8.81e-05 | 85 | 109 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 8.81e-05 | 85 | 109 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.10e-04 | 89 | 109 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | ERVK-6 SMARCA5 AP5S1 DDX12P ATRX USP9X ERVK-7 ERVK-10 FANCI ERVK-8 SMARCA2 SMARCA4 CDT1 DDX11L8 SLX4 VCP | 1.75e-04 | 1081 | 109 | 16 | GO:0006259 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 3.69e-04 | 178 | 109 | 6 | GO:0006261 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.07e-04 | 276 | 110 | 8 | GO:0000775 | |
| GeneOntologyCellularComponent | chromosomal region | 3.87e-04 | 421 | 110 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 5.54e-04 | 193 | 110 | 6 | GO:0000779 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 6.29e-04 | 32 | 110 | 3 | GO:0005721 | |
| GeneOntologyCellularComponent | Derlin-1 retrotranslocation complex | 7.53e-04 | 8 | 110 | 2 | GO:0036513 | |
| GeneOntologyCellularComponent | spindle | 8.63e-04 | 471 | 110 | 9 | GO:0005819 | |
| GeneOntologyCellularComponent | sperm annulus | 9.64e-04 | 9 | 110 | 2 | GO:0097227 | |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 1.20e-03 | 10 | 110 | 2 | GO:0031390 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 1.20e-03 | 10 | 110 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | bBAF complex | 1.20e-03 | 10 | 110 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.21e-03 | 307 | 110 | 7 | GO:0000793 | |
| Domain | SNF2_N | 6.79e-07 | 32 | 99 | 5 | IPR000330 | |
| Domain | SNF2_N | 6.79e-07 | 32 | 99 | 5 | PF00176 | |
| Domain | BRK | 2.86e-06 | 6 | 99 | 3 | SM00592 | |
| Domain | BRK_domain | 2.86e-06 | 6 | 99 | 3 | IPR006576 | |
| Domain | BRK | 2.86e-06 | 6 | 99 | 3 | PF07533 | |
| Domain | SnAC | 2.78e-05 | 2 | 99 | 2 | SM01314 | |
| Domain | Gln-Leu-Gln_QLQ | 2.78e-05 | 2 | 99 | 2 | IPR014978 | |
| Domain | SnAC | 2.78e-05 | 2 | 99 | 2 | IPR029295 | |
| Domain | SnAC | 2.78e-05 | 2 | 99 | 2 | PF14619 | |
| Domain | QLQ | 2.78e-05 | 2 | 99 | 2 | SM00951 | |
| Domain | QLQ | 2.78e-05 | 2 | 99 | 2 | PS51666 | |
| Domain | QLQ | 2.78e-05 | 2 | 99 | 2 | PF08880 | |
| Domain | Chemokine_CXCR_1/2 | 2.78e-05 | 2 | 99 | 2 | IPR000174 | |
| Domain | ARM-type_fold | 7.93e-05 | 339 | 99 | 9 | IPR016024 | |
| Domain | TOM1 | 8.32e-05 | 3 | 99 | 2 | IPR014645 | |
| Domain | SAPS | 8.32e-05 | 3 | 99 | 2 | IPR007587 | |
| Domain | SAPS | 8.32e-05 | 3 | 99 | 2 | PF04499 | |
| Domain | P-loop_NTPase | TANC2 SMARCA5 ATRX SEPTIN4 MYO7B RNF213 CHD9 ARL2 GNL2 SMARCA2 SMARCA4 SEPTIN7 VCP NLRP5 | 1.49e-04 | 848 | 99 | 14 | IPR027417 |
| Domain | HSA | 1.66e-04 | 4 | 99 | 2 | SM00573 | |
| Domain | HSA | 1.66e-04 | 4 | 99 | 2 | PS51204 | |
| Domain | HSA_dom | 1.66e-04 | 4 | 99 | 2 | IPR014012 | |
| Domain | HSA | 1.66e-04 | 4 | 99 | 2 | PF07529 | |
| Domain | Helicase_C | 2.62e-04 | 107 | 99 | 5 | PF00271 | |
| Domain | HELICc | 2.62e-04 | 107 | 99 | 5 | SM00490 | |
| Domain | Helicase_C | 2.74e-04 | 108 | 99 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 2.86e-04 | 109 | 99 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.86e-04 | 109 | 99 | 5 | PS51192 | |
| Domain | DEXDc | 2.86e-04 | 109 | 99 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.98e-04 | 110 | 99 | 5 | IPR014001 | |
| Domain | - | 4.11e-04 | 6 | 99 | 2 | 1.20.58.160 | |
| Domain | GAT | 4.11e-04 | 6 | 99 | 2 | PS50909 | |
| Domain | GAT_dom | 4.11e-04 | 6 | 99 | 2 | IPR004152 | |
| Domain | GAT | 4.11e-04 | 6 | 99 | 2 | PF03127 | |
| Domain | ENTH_VHS | 4.78e-04 | 29 | 99 | 3 | IPR008942 | |
| Domain | DM | 5.74e-04 | 7 | 99 | 2 | PF00751 | |
| Domain | DM_2 | 5.74e-04 | 7 | 99 | 2 | PS50809 | |
| Domain | DM | 5.74e-04 | 7 | 99 | 2 | SM00301 | |
| Domain | - | 5.74e-04 | 7 | 99 | 2 | 4.10.1040.10 | |
| Domain | DM_1 | 5.74e-04 | 7 | 99 | 2 | PS40000 | |
| Domain | Carb_sulfotransferase-rel | 5.74e-04 | 7 | 99 | 2 | IPR018011 | |
| Domain | CXCR4/ACKR2 | 5.74e-04 | 7 | 99 | 2 | IPR001277 | |
| Domain | DM_DNA-bd | 5.74e-04 | 7 | 99 | 2 | IPR001275 | |
| Domain | - | SMARCA5 ATRX SEPTIN4 MYO7B RNF213 CHD9 ARL2 GNL2 SMARCA2 SMARCA4 SEPTIN7 VCP | 5.78e-04 | 746 | 99 | 12 | 3.40.50.300 |
| Domain | DMRT/dsx/mab-3 | 7.63e-04 | 8 | 99 | 2 | IPR026607 | |
| Domain | VHS | 9.77e-04 | 9 | 99 | 2 | PF00790 | |
| Domain | VHS | 9.77e-04 | 9 | 99 | 2 | PS50179 | |
| Domain | VHS | 9.77e-04 | 9 | 99 | 2 | SM00288 | |
| Domain | VHS_dom | 9.77e-04 | 9 | 99 | 2 | IPR002014 | |
| Domain | Sulfotransfer_2 | 1.77e-03 | 12 | 99 | 2 | PF03567 | |
| Domain | Sulfotransferase | 1.77e-03 | 12 | 99 | 2 | IPR005331 | |
| Domain | Znf_TRAF | 1.77e-03 | 12 | 99 | 2 | IPR001293 | |
| Domain | Septin | 2.09e-03 | 13 | 99 | 2 | PF00735 | |
| Domain | G_SEPTIN_dom | 2.09e-03 | 13 | 99 | 2 | IPR030379 | |
| Domain | ZF_TRAF | 2.09e-03 | 13 | 99 | 2 | PS50145 | |
| Domain | G_SEPTIN | 2.09e-03 | 13 | 99 | 2 | PS51719 | |
| Domain | Annexin | 2.43e-03 | 14 | 99 | 2 | IPR001464 | |
| Domain | Septin | 2.43e-03 | 14 | 99 | 2 | IPR016491 | |
| Domain | - | 2.43e-03 | 14 | 99 | 2 | 3.90.890.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.05e-03 | 459 | 99 | 8 | IPR013083 | |
| Domain | ARM-like | 3.15e-03 | 270 | 99 | 6 | IPR011989 | |
| Domain | SIAH-type | 3.18e-03 | 16 | 99 | 2 | IPR013323 | |
| Domain | DH_1 | 4.56e-03 | 63 | 99 | 3 | PS00741 | |
| Domain | USP_CS | 5.19e-03 | 66 | 99 | 3 | IPR018200 | |
| Pubmed | RABEP2 TPP2 USP9X POLR2E RNF213 PPP6R1 COLGALT1 PPFIA3 TAB3 WWC2 ARL2 MTMR4 AKAP9 SSH1 PTPRM FANCI CLTC GNL2 TTI1 PPP6R3 XPOT NIN | 1.75e-12 | 1049 | 110 | 22 | 27880917 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-5 ERVK-19 ERVK-24 | 1.93e-11 | 94 | 110 | 9 | 21542922 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 9.47e-11 | 4 | 110 | 4 | 10469592 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 7983737 | ||
| Pubmed | 2.25e-10 | 12 | 110 | 5 | 14557543 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 4.72e-10 | 5 | 110 | 4 | 12629516 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMARCA5 NUP85 ATRX USP9X WDCP CLTC GNL2 SMARCA2 SMARCA4 MED23 RPL5 SLX4 PPP6R3 | 1.56e-09 | 440 | 110 | 13 | 34244565 |
| Pubmed | NUP85 USP9X PPP6R1 NDUFS2 TAB3 STX18 FANCI CLTC SMARCA4 TTI1 SEC63 RPL5 VCP PPP6R3 XPOT | 2.67e-09 | 657 | 110 | 15 | 36180527 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TOM1L2 NUP85 USP9X POLR2E TOM1 PPP6R1 SEC31A NDUFS2 STX18 FANCI CLTC SEPTIN7 SEC63 VCP PPP6R3 XPOT | 4.79e-08 | 942 | 110 | 16 | 31073040 |
| Pubmed | USP9X PPP6R1 NDUFS2 TAB3 STX18 FANCI CLTC SMARCA4 RPL5 VCP XPOT | 7.64e-08 | 408 | 110 | 11 | 33766124 | |
| Pubmed | TOM1L2 TPP2 USP9X TOM1 SEC31A NDUFS2 SCUBE2 FANCI CLTC SMARCA2 SMARCA4 RPL5 PPP6R3 | 1.14e-07 | 634 | 110 | 13 | 34591612 | |
| Pubmed | 1.31e-07 | 183 | 110 | 8 | 23956138 | ||
| Pubmed | TPP2 USP34 SMARCA5 USP9X FANCI CLTC GNL2 SMARCA2 SMARCA4 RPL5 VCP PPP6R3 XPOT | 1.60e-07 | 653 | 110 | 13 | 22586326 | |
| Pubmed | 2.80e-07 | 18 | 110 | 4 | 18664271 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 3.06e-07 | 5 | 110 | 3 | 11401426 | |
| Pubmed | Recruitment of clathrin onto endosomes by the Tom1-Tollip complex. | 3.06e-07 | 5 | 110 | 3 | 16412388 | |
| Pubmed | TANC2 USP34 SMARCA5 ZNF618 POLR2E BIRC2 RNF213 CHD9 PPP6R1 PPFIA3 FOXP4 GNL2 SMARCA2 SMARCA4 VCP NIN | 4.69e-07 | 1116 | 110 | 16 | 31753913 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 15063128 | ||
| Pubmed | SMARCA5 NUP85 USP9X SEC31A FANCI CLTC SMARCA4 SEPTIN7 RPL5 VCP PPP6R3 XPOT | 8.98e-07 | 638 | 110 | 12 | 33239621 | |
| Pubmed | TANC2 RABEP2 TPP2 ZNF618 USP9X PPP6R1 SEC31A PPFIA3 ARHGEF11 AKAP9 SSH1 CLTC SMARCA4 SEPTIN7 | 2.22e-06 | 963 | 110 | 14 | 28671696 | |
| Pubmed | TPP2 USP34 NUP85 POLR2E TOM1 RNF213 PPP6R1 COLGALT1 NDUFS2 STX18 FANCI CLTC GNL2 SEC63 VCP PPP6R3 XPOT | 2.84e-06 | 1440 | 110 | 17 | 30833792 | |
| Pubmed | 3.01e-06 | 125 | 110 | 6 | 29467281 | ||
| Pubmed | 3.63e-06 | 10 | 110 | 3 | 12970426 | ||
| Pubmed | TPP2 SMARCA5 CHD9 SEC31A CLTC SMARCA4 SEPTIN7 RPL5 VCP PPP6R3 | 4.03e-06 | 494 | 110 | 10 | 26831064 | |
| Pubmed | 4.96e-06 | 396 | 110 | 9 | 26687479 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SMARCA5 HIVEP1 ATRX WTAP WWC2 SSH1 CLTC SMARCA2 SMARCA4 PACS2 CDT1 PPP6R3 | 6.51e-06 | 774 | 110 | 12 | 15302935 |
| Pubmed | 6.63e-06 | 12 | 110 | 3 | 15140983 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SMARCA5 ZNF618 CHD9 SEC31A USP9Y NDUFS2 WTAP CLTC GNL2 SMARCA4 SEC63 MED23 RPL5 VCP | 8.38e-06 | 1082 | 110 | 14 | 38697112 |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 8670841 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21555225 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19585580 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23163725 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21254176 | ||
| Pubmed | Attenuation of murine allergic airway inflammation with a CXCR1/CXCR2 chemokine receptor inhibitor. | 9.91e-06 | 2 | 110 | 2 | 30218547 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26302999 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21915051 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18668539 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 9.91e-06 | 2 | 110 | 2 | 23076393 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 16987681 | ||
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 9.91e-06 | 2 | 110 | 2 | 9603422 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22076427 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15576411 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 12442335 | ||
| Pubmed | Roles of mechanical force and CXCR1/CXCR2 in shear-stress-induced endothelial cell migration. | 9.91e-06 | 2 | 110 | 2 | 21989491 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23276717 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27097303 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15240517 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 9.91e-06 | 2 | 110 | 2 | 33027072 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28038711 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23872584 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 9.91e-06 | 2 | 110 | 2 | 23963727 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 30341468 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 7929358 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10988300 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 9.91e-06 | 2 | 110 | 2 | 31375262 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21036625 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 9.91e-06 | 2 | 110 | 2 | 23088494 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20082763 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 9060628 | ||
| Pubmed | The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. | 9.91e-06 | 2 | 110 | 2 | 20044480 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17075831 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26791948 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20333683 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 34812766 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11397869 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 9.91e-06 | 2 | 110 | 2 | 9460924 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15618253 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 12925892 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 9.91e-06 | 2 | 110 | 2 | 32855269 | |
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 9.91e-06 | 2 | 110 | 2 | 30478150 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17996233 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15028716 | ||
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 9.91e-06 | 2 | 110 | 2 | 22721696 | |
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 9.91e-06 | 2 | 110 | 2 | 12895410 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18508913 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11719516 | ||
| Pubmed | CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. | 9.91e-06 | 2 | 110 | 2 | 19401689 | |
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 9.91e-06 | 2 | 110 | 2 | 25808524 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15772681 | ||
| Pubmed | A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients. | 9.91e-06 | 2 | 110 | 2 | 17360650 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22171941 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27974825 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29577511 | ||
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 9.91e-06 | 2 | 110 | 2 | 19144648 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 8384312 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25022956 | ||
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 9.91e-06 | 2 | 110 | 2 | 28706277 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 7829970 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21092585 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26087179 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22152684 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21937426 | ||
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 9.91e-06 | 2 | 110 | 2 | 29391527 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 34730557 | ||
| Pubmed | Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2. | 9.91e-06 | 2 | 110 | 2 | 12239185 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20016196 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 37634210 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26551623 | ||
| Interaction | CSNK1E interactions | ZNF618 USP9X USP9Y CEP128 MTMR4 AKAP9 WDCP CLTC SMARCA4 SLX4 PPP6R3 | 6.81e-07 | 311 | 105 | 11 | int:CSNK1E |
| Interaction | BRCA1 interactions | TPP2 SMARCA5 SDK2 HIVEP1 USP9X POLR2E CHD9 PPP6R1 SEC31A NDUFS2 FANCI CLTC SMARCA2 SMARCA4 SEPTIN7 RPL5 SLX4 VCP PPP6R3 LCMT1 | 6.03e-06 | 1249 | 105 | 20 | int:BRCA1 |
| Interaction | SIRT6 interactions | SMARCA5 NUP85 ATRX USP9X WDCP CLTC GNL2 SMARCA2 SMARCA4 MED23 RPL5 SLX4 PPP6R3 | 2.33e-05 | 628 | 105 | 13 | int:SIRT6 |
| Interaction | YWHAE interactions | TANC2 HIVEP1 ING1 ARHGEF5 DISC1 CHST11 PLEKHG5 WTAP TAB3 WWC2 ARL2 MTMR4 AKAP9 SSH1 CLTC PACS2 TNFAIP8 VCP NIN | 2.37e-05 | 1256 | 105 | 19 | int:YWHAE |
| Interaction | LMBR1L interactions | TOM1L2 NUP85 USP9X POLR2E TOM1 PPP6R1 SEC31A NDUFS2 STX18 FANCI CLTC SEPTIN7 SEC63 VCP PPP6R3 XPOT | 3.02e-05 | 946 | 105 | 16 | int:LMBR1L |
| Interaction | NDE1 interactions | 3.39e-05 | 117 | 105 | 6 | int:NDE1 | |
| Interaction | CEP63 interactions | 4.24e-05 | 179 | 105 | 7 | int:CEP63 | |
| Interaction | YWHAZ interactions | TANC2 HIVEP1 ING1 ARHGEF5 DISC1 PPFIA3 PLEKHG5 WTAP TAB3 WWC2 ARL2 MTMR4 AKAP9 SSH1 CLTC PACS2 RPL5 VCP NIN | 4.62e-05 | 1319 | 105 | 19 | int:YWHAZ |
| Interaction | CXCL3 interactions | 4.80e-05 | 14 | 105 | 3 | int:CXCL3 | |
| Interaction | AR interactions | TOM1L2 USP34 SMARCA5 HIVEP1 ATRX ING1 TOM1 RNF213 FOXP4 TRAF4 CLTC SMARCA2 SMARCA4 MED23 VCP XPOT | 5.34e-05 | 992 | 105 | 16 | int:AR |
| Interaction | ARHGEF2 interactions | 5.86e-05 | 256 | 105 | 8 | int:ARHGEF2 | |
| Interaction | UBE2J1 interactions | 8.28e-05 | 199 | 105 | 7 | int:UBE2J1 | |
| Interaction | SSX2 interactions | 8.80e-05 | 45 | 105 | 4 | int:SSX2 | |
| Interaction | KRT8 interactions | 1.03e-04 | 441 | 105 | 10 | int:KRT8 | |
| Interaction | KDM1A interactions | USP34 SMARCA5 HIVEP1 USP9X BIRC2 PPP6R1 TRAF4 ARL2 AKAP9 WDCP KRT40 SMARCA2 MED23 PPP6R3 NIN | 1.07e-04 | 941 | 105 | 15 | int:KDM1A |
| Interaction | UBC interactions | 1.13e-04 | 446 | 105 | 10 | int:UBC | |
| Interaction | EXOC4 interactions | 1.27e-04 | 213 | 105 | 7 | int:EXOC4 | |
| Interaction | RBBP5 interactions | 1.30e-04 | 287 | 105 | 8 | int:RBBP5 | |
| Interaction | GTSE1 interactions | 1.34e-04 | 215 | 105 | 7 | int:GTSE1 | |
| Interaction | RHOBTB1 interactions | 1.45e-04 | 152 | 105 | 6 | int:RHOBTB1 | |
| Cytoband | 17q22-q23 | 8.33e-05 | 6 | 109 | 2 | 17q22-q23 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 2.13e-04 | 6 | 69 | 2 | 699 | |
| GeneFamily | CD molecules|C-X-C motif chemokine receptors | 2.13e-04 | 6 | 69 | 2 | 1094 | |
| GeneFamily | Septins | 1.09e-03 | 13 | 69 | 2 | 732 | |
| GeneFamily | Ubiquitin specific peptidases | 1.28e-03 | 56 | 69 | 3 | 366 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.61e-03 | 20 | 69 | 2 | 548 | |
| GeneFamily | Ring finger proteins | 3.99e-03 | 275 | 69 | 5 | 58 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.37e-05 | 203 | 98 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPP2 SMARCA5 ATRX TSPOAP1 ZNF618 USP9X CHD9 CEP128 CHST8 AKAP9 WDCP GNL2 TTI1 TNFAIP8 SEPTIN7 CRISPLD1 CXCR2 | 5.49e-05 | 1252 | 98 | 17 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.12e-05 | 291 | 98 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.93e-07 | 193 | 101 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-06 | 190 | 101 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-06 | 193 | 101 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-05 | 159 | 101 | 5 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 167 | 101 | 5 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.78e-05 | 181 | 101 | 5 | cfc3ed541d93158ce26641ea30b7573d93600a11 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.09e-05 | 189 | 101 | 5 | b0fcbe13a91a4b8dfa507b7a484f45477ef31609 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.09e-05 | 189 | 101 | 5 | d5d25f4151ea96e2d4b3a0e0910e7ff995eaf752 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.09e-05 | 189 | 101 | 5 | 0f0607642eecc66222d23afe6d77b6872343cb8e | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 7.27e-05 | 190 | 101 | 5 | 5dca8654964c41580fa3b094579fe7cb296d406f | |
| ToppCell | BAL-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 190 | 101 | 5 | d55b9f9b82bd2b2e1ea2446813fce04f04a1dcdf | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 191 | 101 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-05 | 191 | 101 | 5 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 191 | 101 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 191 | 101 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 193 | 101 | 5 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 193 | 101 | 5 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.21e-05 | 195 | 101 | 5 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | BLOOD--(1)_Activated_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.21e-05 | 195 | 101 | 5 | 45515d5da8a8c8242eb70a1bea24fe44eca5407b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 195 | 101 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-05 | 196 | 101 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.62e-05 | 197 | 101 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 8.62e-05 | 197 | 101 | 5 | b59369f78bf99a4154a46c331d4dad737d8a5f38 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.83e-05 | 198 | 101 | 5 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 198 | 101 | 5 | 06888fe2d42ac66ac12157608becd42764e0d034 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 8.83e-05 | 198 | 101 | 5 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.83e-05 | 198 | 101 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 8.83e-05 | 198 | 101 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.04e-05 | 199 | 101 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.04e-05 | 199 | 101 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.04e-05 | 199 | 101 | 5 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Glia_progenitor_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 6c1b7b0f3cd35d8cfee181ea83c73127dbc41ac5 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 107 | 101 | 4 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 107 | 101 | 4 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.98e-06 | 197 | 102 | 8 | 3748_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 2.47e-05 | 191 | 102 | 7 | 4647_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 6299_UP | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; HL60; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 2383_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 7227_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 7138_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 3681_DN | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 6448_DN | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.06e-05 | 18 | 101 | 3 | EFO_0006831, EFO_0006896 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 3.47e-05 | 3 | 101 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.15e-04 | 5 | 101 | 2 | C3281201 | |
| Disease | Abnormality of radial ray | 1.97e-04 | 33 | 101 | 3 | C4228778 | |
| Disease | granulocyte percentage of myeloid white cells | 3.27e-04 | 268 | 101 | 6 | EFO_0007997 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 4.11e-04 | 9 | 101 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 8.83e-04 | 13 | 101 | 2 | C0265338 | |
| Disease | Fanconi anemia | 1.03e-03 | 14 | 101 | 2 | cv:C0015625 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.35e-03 | 16 | 101 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | serum non-albumin protein measurement | 1.54e-03 | 361 | 101 | 6 | EFO_0004568 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.59e-03 | 67 | 101 | 3 | C3463824 | |
| Disease | Bone marrow hypocellularity | 1.71e-03 | 18 | 101 | 2 | C1855710 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 2.12e-03 | 20 | 101 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | bone density, lean body mass | 2.33e-03 | 21 | 101 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | Fanconi Anemia | 3.31e-03 | 25 | 101 | 2 | C0015625 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QNDLRLQMEAQRICL | 1106 | Q99996 | |
| RLLERVNMCRIQRAD | 41 | Q9NRJ3 | |
| LRHQLMLCRQQLRNL | 891 | Q6ZU80 | |
| INILTQRCNAQRMMI | 41 | Q9UJ72 | |
| LIRDCNNNVQSMRRT | 1351 | Q12774 | |
| RKMIGNRERCQNLVS | 36 | Q0P651 | |
| CRRLQLRDLIISEMQ | 866 | O15085 | |
| AQMTRCPEQEQRLQR | 436 | Q9H211 | |
| AVARQVESMCRLQQQ | 56 | Q9NUS5 | |
| VLRDCLLRNRRQMEV | 336 | Q9NRI5 | |
| LCSLRTEMERVQQEQ | 481 | Q9H5N1 | |
| LQLLQVCREVVVRTM | 1046 | O95153 | |
| RTQRMLNQCLESLVQ | 211 | Q5JSJ4 | |
| RQRMQDCQRELQSLL | 96 | P36404 | |
| LRRCLSQQADVRLML | 591 | Q9NVI1 | |
| MRCQCETVLANNRRE | 261 | Q6A162 | |
| TLRRIRQCSMVQNHR | 451 | O43300 | |
| CDANTEMQQILTRVR | 516 | Q13823 | |
| CRKRGMEVVQLNLSR | 31 | Q13572 | |
| MRQATVQQLVDLLCR | 66 | O43187 | |
| MIRRSQEVQACAQER | 256 | Q69YI7 | |
| QLRERLAVLCRQMSQ | 251 | O75145 | |
| LQSVCVRLFSNQMRQ | 266 | Q7Z3E5 | |
| RILRLRFMCQQQKDS | 201 | O95972 | |
| LRCSVLEIEQSMNRV | 411 | Q9UK73 | |
| LKVLRICEQRQMTEQ | 451 | Q9BW27 | |
| ICEQRQMTEQVRSIC | 456 | Q9BW27 | |
| LMRTQVIQETCERRN | 276 | P25025 | |
| LQRFQQERTRCMIEI | 1256 | Q9ULK4 | |
| DRSTAQCRVQMQVVQ | 336 | Q8IVH2 | |
| QCQRGLLRSRRNVVM | 301 | Q9HB14 | |
| RAIMNNRELLDQCQV | 456 | P59047 | |
| LRRRQLTCTEEMAQR | 96 | Q15599 | |
| VIAMEELKQCRLQQR | 111 | Q9Y2D4 | |
| SRLICTARQQQNMLR | 836 | Q86VP3 | |
| TQRLVQVMRRRRCVG | 96 | Q9HBH1 | |
| RQVRELQMRLDIRHC | 1041 | Q9NYA4 | |
| EMRQSLRIIAQCLNK | 336 | O75306 | |
| RRQLVDEVMCTRKLQ | 386 | Q96M91 | |
| MQNEAIEQVRAICLR | 411 | P87889 | |
| MQNEAIEQVRAICLR | 411 | Q9YNA8 | |
| MQNEAIEQVRAICLR | 411 | P62683 | |
| MQNEAIEQVRAICLR | 411 | P63145 | |
| MQNEAIEQVRAICLR | 411 | Q9HDB9 | |
| MQNEAIEQVRAICLR | 411 | Q7LDI9 | |
| MQNEAIEQVRAICLR | 411 | P63130 | |
| MQNEAIEQVRAICLR | 411 | P62685 | |
| MQNEAIEQVRAICLR | 411 | P63126 | |
| MQNEAIEQVRAICLR | 411 | P62684 | |
| LISCVQRILMNRRLQ | 2401 | P46100 | |
| DRVMINRLDSICQTV | 2261 | Q3L8U1 | |
| NCLLVVERQRVMAAQ | 151 | Q9Y5R5 | |
| TRVTNRNRQCEMLKQ | 226 | P48745 | |
| AQQMSQIVSCEVRLR | 286 | Q9H336 | |
| CAQEQMRLRAQVRLL | 26 | Q08830 | |
| CTLIAERQRVMAAQV | 126 | Q5VZB9 | |
| QLINDRCVDMQRSRH | 281 | A8MPP1 | |
| TLMRTQVIQESCERR | 266 | P25024 | |
| TMAQRLVRVLQICAG | 141 | Q9NSP4 | |
| SVQLINNRCVDMQRS | 296 | Q92771 | |
| VLMRNICATLLQERG | 601 | Q9UH90 | |
| CRMLIQENQELGRQL | 161 | Q15007 | |
| ERMLRALQAQEIECR | 356 | Q8NBJ5 | |
| RVKRRLLMETCAVNN | 276 | Q9NQ36 | |
| CIVRNRMGALLQRQT | 91 | Q58EX2 | |
| EMQRARTTRCLQLLA | 121 | P0C7I6 | |
| CVRELRSRRVNMVQT | 1126 | P28827 | |
| NRAVRERQMLCRQLA | 196 | Q6ICC9 | |
| QRQQTCPTCRMDVLR | 321 | Q86TM6 | |
| NCARQEAVRMVRVLT | 841 | Q93008 | |
| ECMLRNVSVRLAQQI | 1211 | Q93008 | |
| CDMARQQRAQTLRVR | 251 | Q6ZMZ0 | |
| CQRMQEENITRALIV | 91 | P19388 | |
| LNFQRQLRQEVVACM | 386 | P51531 | |
| QLRQEVVACMRRDTT | 391 | P51531 | |
| CIQSMTRLVVKERNR | 411 | O43236 | |
| RLRSMNRQLQINVDC | 576 | Q8N5C8 | |
| RFGQIMIENLRRRQC | 236 | Q9UIC8 | |
| ERLTQMRNEYERQCR | 531 | Q8N4C6 | |
| RRMLHCVQRALIRSQ | 211 | Q9UK53 | |
| NFQRQLRQEVVVCMR | 411 | P51532 | |
| MIVRVTNRDIICQIA | 51 | P46777 | |
| IQRLLLRVEEECRQM | 1361 | Q9HCD6 | |
| LLNECREMLHQIIQR | 131 | O95379 | |
| MQNEAIEQVRAICLR | 411 | P63128 | |
| MNVTRREQHVNRCLD | 306 | Q8IY92 | |
| QHLQVMINLLRCEDR | 76 | Q8WYL5 | |
| IRKNRMALFQQLTCV | 461 | Q13490 | |
| QLRRLQEERTCKVCM | 561 | Q13490 | |
| CLRAMLSANIRQNLQ | 666 | Q00610 | |
| RSQQERKRVMQEACA | 151 | Q9H2A9 | |
| VLHQMRRDQVTDTCR | 76 | Q9NPF2 | |
| TQLCRNINRVKICME | 3081 | Q63HN8 | |
| NESCTRNMRRVVLLL | 3551 | Q63HN8 | |
| NACMRQRQERQRLAA | 526 | O94827 | |
| RQNIAERLLRVMCAD | 466 | Q5T7W0 | |
| MRQVSKDVCRLREQS | 1146 | Q6AWC2 | |
| TCSDEKIRMNRVVRN | 76 | P55072 | |
| LCQRLTQRYVSVMNR | 496 | Q76KD6 | |
| SRVNRRQMPDNRVQC | 146 | Q16181 | |
| LELLQELNRTCRAMQ | 251 | O60784 | |
| ELNRTCRAMQQRVLE | 256 | O60784 | |
| QIFMRTCSEAIQQLR | 101 | Q9P2W9 | |
| LELMNQCRHINIRVD | 586 | P29144 | |
| MVNVICQLIVMARNR | 336 | Q9UGP8 | |
| MCALVSRQRQELQEL | 281 | Q9BUZ4 | |
| INCARQEAIRMVRVL | 841 | O00507 | |
| CDIIRLSREQMIQVQ | 216 | Q9UPN7 | |
| RRNTLIKDTMREQCI | 166 | O43592 | |
| QMFQRLCIHVIQRLR | 2371 | Q70CQ2 | |
| VEILSRNLVEMQRCL | 561 | Q9H6R7 | |
| RNLVEMQRCLSELTN | 566 | Q9H6R7 | |
| SRTAMELQRRCNTLI | 991 | O60264 | |
| ELLQELNRTCRAMQQ | 256 | Q6ZVM7 | |
| LNRTCRAMQQRIVEL | 261 | Q6ZVM7 | |
| QPNIMQLRDRLCRAQ | 776 | O94979 | |
| CEIVRLSRDQMLQIQ | 216 | Q5H9R7 | |
| REMRRTASEQINCTQ | 1361 | P15822 | |
| DERIFMLLRQVCQLL | 481 | O43156 | |
| SEMVELNRLIQRIRC | 356 | Q7RTS7 | |
| AMRQRTVQLQALCRG | 831 | Q6PIF6 |